Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
135.4
USD
|
+1.69%
|
|
+3.27%
|
+79.20%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,951
|
4,213
|
8,751
|
5,275
|
7,674
|
13,209
|
-
|
-
|
Enterprise Value (EV)
1 |
18,440
|
17,486
|
22,033
|
19,496
|
21,448
|
22,295
|
22,601
|
21,301
|
P/E ratio
|
-17
x
|
10.6
x
|
9.7
x
|
12.9
x
|
13.2
x
|
4.84
x
|
15.4
x
|
13.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.21
x
|
0.24
x
|
0.45
x
|
0.28
x
|
0.37
x
|
0.65
x
|
0.62
x
|
0.59
x
|
EV / Revenue
|
1
x
|
0.99
x
|
1.13
x
|
1.02
x
|
1.04
x
|
1.09
x
|
1.06
x
|
0.96
x
|
EV / EBITDA
|
6.81
x
|
5.56
x
|
6.33
x
|
5.62
x
|
6.06
x
|
6.17
x
|
6.02
x
|
5.33
x
|
EV / FCF
|
32.8
x
|
6.1
x
|
24.2
x
|
60.7
x
|
13.2
x
|
8.48
x
|
17
x
|
13.8
x
|
FCF Yield
|
3.05%
|
16.4%
|
4.13%
|
1.65%
|
7.57%
|
11.8%
|
5.88%
|
7.25%
|
Price to Book
|
-10.7
x
|
151
x
|
8.52
x
|
2.03
x
|
2.42
x
|
2.45
x
|
2.12
x
|
1.84
x
|
Nbr of stocks (in thousands)
|
103,895
|
105,517
|
107,126
|
108,123
|
101,552
|
97,683
|
-
|
-
|
Reference price
2 |
38.03
|
39.93
|
81.69
|
48.79
|
75.57
|
135.2
|
135.2
|
135.2
|
Announcement Date
|
2/24/20
|
2/9/21
|
2/7/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,479
|
17,640
|
19,485
|
19,174
|
20,548
|
20,382
|
21,312
|
22,227
|
EBITDA
1 |
2,706
|
3,146
|
3,483
|
3,469
|
3,541
|
3,615
|
3,753
|
3,997
|
EBIT
1 |
1,856
|
2,289
|
2,628
|
2,628
|
2,671
|
2,779
|
2,910
|
3,155
|
Operating Margin
|
10.04%
|
12.98%
|
13.49%
|
13.71%
|
13%
|
13.63%
|
13.66%
|
14.19%
|
Earnings before Tax (EBT)
1 |
296
|
671
|
1,888
|
1,344
|
1,617
|
4,374
|
1,977
|
2,213
|
Net income
1 |
-232
|
399
|
914
|
411
|
611
|
2,827
|
886.5
|
968.4
|
Net margin
|
-1.26%
|
2.26%
|
4.69%
|
2.14%
|
2.97%
|
13.87%
|
4.16%
|
4.36%
|
EPS
2 |
-2.240
|
3.750
|
8.420
|
3.790
|
5.710
|
27.91
|
8.799
|
9.708
|
Free Cash Flow
1 |
563
|
2,867
|
910
|
321
|
1,623
|
2,630
|
1,328
|
1,545
|
FCF margin
|
3.05%
|
16.25%
|
4.67%
|
1.67%
|
7.9%
|
12.9%
|
6.23%
|
6.95%
|
FCF Conversion (EBITDA)
|
20.81%
|
91.13%
|
26.13%
|
9.25%
|
45.83%
|
72.75%
|
35.39%
|
38.66%
|
FCF Conversion (Net income)
|
-
|
718.55%
|
99.56%
|
78.1%
|
265.63%
|
93.04%
|
149.84%
|
159.54%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/20
|
2/9/21
|
2/7/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,856
|
4,745
|
4,638
|
4,801
|
4,990
|
5,021
|
5,082
|
5,066
|
5,379
|
5,368
|
4,993
|
4,864
|
5,144
|
5,430
|
5,224
|
EBITDA
1 |
1,017
|
888
|
843
|
841
|
897
|
832
|
843
|
854
|
1,012
|
1,024
|
862.7
|
820.9
|
930.1
|
949.2
|
908.7
|
EBIT
1 |
816
|
685
|
627
|
632
|
684
|
615
|
630
|
630
|
796
|
816
|
648.5
|
616.3
|
722.5
|
740.2
|
702.4
|
Operating Margin
|
16.8%
|
14.44%
|
13.52%
|
13.16%
|
13.71%
|
12.25%
|
12.4%
|
12.44%
|
14.8%
|
15.2%
|
12.99%
|
12.67%
|
14.05%
|
13.63%
|
13.45%
|
Earnings before Tax (EBT)
1 |
528
|
378
|
265
|
380
|
321
|
380
|
373
|
345
|
519
|
3,084
|
431
|
400
|
527.3
|
478.3
|
465.3
|
Net income
1 |
249
|
140
|
38
|
131
|
102
|
143
|
123
|
101
|
244
|
2,151
|
182.8
|
160.8
|
224.2
|
214
|
201
|
Net margin
|
5.13%
|
2.95%
|
0.82%
|
2.73%
|
2.04%
|
2.85%
|
2.42%
|
1.99%
|
4.54%
|
40.07%
|
3.66%
|
3.31%
|
4.36%
|
3.94%
|
3.85%
|
EPS
2 |
2.290
|
1.280
|
0.3500
|
1.160
|
0.9200
|
1.320
|
1.150
|
0.9400
|
2.300
|
21.38
|
1.785
|
1.633
|
2.180
|
2.266
|
2.002
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/7/22
|
4/20/22
|
7/21/22
|
10/20/22
|
2/9/23
|
4/25/23
|
7/31/23
|
10/30/23
|
2/8/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
14,489
|
13,273
|
13,282
|
14,221
|
13,774
|
9,086
|
9,392
|
8,092
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.354
x
|
4.219
x
|
3.813
x
|
4.099
x
|
3.89
x
|
2.513
x
|
2.502
x
|
2.025
x
|
Free Cash Flow
1 |
563
|
2,867
|
910
|
321
|
1,623
|
2,630
|
1,328
|
1,545
|
ROE (net income / shareholders' equity)
|
6.98%
|
31.5%
|
173%
|
68.6%
|
44.4%
|
25.7%
|
15.1%
|
15.4%
|
ROA (Net income/ Total Assets)
|
1.23%
|
3.34%
|
3.34%
|
2.72%
|
2.2%
|
5.11%
|
2.94%
|
3.02%
|
Assets
1 |
-18,891
|
11,958
|
27,342
|
15,118
|
27,734
|
55,318
|
30,153
|
32,099
|
Book Value Per Share
2 |
-3.560
|
0.2600
|
9.590
|
24.00
|
31.20
|
55.20
|
63.80
|
73.40
|
Cash Flow per Share
2 |
11.90
|
32.10
|
14.40
|
9.800
|
22.70
|
18.70
|
18.80
|
20.10
|
Capex
1 |
670
|
540
|
658
|
762
|
751
|
820
|
851
|
880
|
Capex / Sales
|
3.63%
|
3.06%
|
3.38%
|
3.97%
|
3.65%
|
4.02%
|
3.99%
|
3.96%
|
Announcement Date
|
2/24/20
|
2/9/21
|
2/7/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
135.2
USD Average target price
133.4
USD Spread / Average Target -1.37% Consensus |
1st Jan change
|
Capi.
|
---|
| +79.20% | 13.21B | | +25.52% | 88.99B | | -24.52% | 74.82B | | -5.56% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +70.11% | 13.09B | | +40.44% | 12.9B | | +24.51% | 12.7B |
Other Healthcare Facilities & Services
|